European Medicines Agency Recommends Cautious Use Of Protopic/Protopy And Elidel

... Finalising its safety review of Protopic/Protopy (tacrolimus) and Elidel (pimecrolimus), the European Medicines Agency''s Committee for Medicinal Products for Human Use (CHMP) concluded that the benefit associated with the use of these dermatological medicinal products outweigh the risks, but that they should be used with greater caution in order to reduce potential risks of skin cancer and lymphoma as far as possible... click link for more info. ...